Clinical Trial Update: Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients [NA]

View source ↗

Summary

A completed clinical trial comparing intravenous iohexol (Omnipaque) versus iopamidol (Isovue) on serum creatinine in outpatients with kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Isovue (iopamidol)
• OMNIPAQUE (iohexol)

Snippet

Sponsor: University of Michigan | Conditions: Kidney Disease | NA | Status: COMPLETED